← FDA Drug Approvals (Drugs@FDA)

PIMAVANSERIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2024-01-16

Drug application

FDA Application #

ANDA214925

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIMAVANSERIN

Generic name

PIMAVANSERIN

Active ingredients

PIMAVANSERIN TARTRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2024-01-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown